Compounds > fluconazole

fluconazole and cannabidiol

fluconazole has been researched along with cannabidiol in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Al Saabi, A; Allorge, D; Gaulier, JM; Marquet, P; Picard, N; Sauvage, FL; Tournel, G1
Astatkie, T; Dincheva, I; Kačániová, M; Latkovic, D; Semerdjieva, IB; Sikora, V; Zheljazkov, VD1
Beers, JL; Edginton, AN; Jackson, KD; Yeung, CHT1

Other Studies

4 other study(ies) available for fluconazole and cannabidiol

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Involvement of UDP-glucuronosyltransferases UGT1A9 and UGT2B7 in ethanol glucuronidation, and interactions with common drugs of abuse.
    Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:3

    Topics: Biotransformation; Cannabidiol; Cannabinol; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Ethanol; Fluconazole; Glucuronates; Glucuronosyltransferase; Humans; Illicit Drugs; Intestines; Kidney; Kinetics; Microsomes, Liver; Niflumic Acid; Recombinant Proteins; Substrate Specificity; Tandem Mass Spectrometry; UDP-Glucuronosyltransferase 1A9

2013
Industrial, CBD, and Wild Hemp: How Different Are Their Essential Oil Profile and Antimicrobial Activity?
    Molecules (Basel, Switzerland), 2020, Oct-12, Volume: 25, Issue:20

    Topics: Analysis of Variance; Anti-Infective Agents; Bicyclic Monoterpenes; Candida albicans; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Fluconazole; Microbial Sensitivity Tests; Monoterpenes; Oils, Volatile; Plant Extracts; Polycyclic Sesquiterpenes; Sesquiterpenes

2020
Verifying in vitro-determined enzyme contributions to cannabidiol clearance for exposure predictions in human through physiologically-based pharmacokinetic modeling.
    CPT: pharmacometrics & systems pharmacology, 2023, Volume: 12, Issue:3

    Topics: Adult; Cannabidiol; Child; Child, Preschool; Drug Interactions; Fluconazole; Humans; Itraconazole; Rifampin

2023